SACRAMENTO, CA—August 13, 2026 — Blood Cancer United today announced its endorsement of YES on Prop 38, the California state ballot measure that will fund breakthrough immunology medical research to help prevent and cure blood cancers, as well as other serious illnesses like Alzheimer's, Parkinson’s, and heart disease.
“Breakthroughs in cancer and chronic disease depend on sustained, reliable investment, and funding instability can delay lifesaving clinical trials for patients with few options,” said Adam Zarrin, director of state government affairs at Blood Cancer United. “We are proud to support Prop 38 because it will strengthen California’s research and clinical trial infrastructure, helping ensure patients can access cutting-edge therapies sooner while accelerating the search for cures.”
Prop 38 will support immunology medical research conducted by eligible California nonprofit universities and research institutions to advance treatments for diseases affecting millions of families. Blood Cancer United joins a growing coalition of patient advocates, physicians, nurses, researchers, community organizations, and others supporting YES on Prop 38.
For more information about the measure or the campaign, visit YesOn38.com.
###
About Blood Cancer United®
Blood Cancer United® (formerly The Leukemia & Lymphoma Society) is the largest global nonprofit focused on blood cancer patient support, research, and advocacy. Since their founding in 1949, the organization has consistently evolved to better serve people affected by all 100-plus types of blood cancer. Blood Cancer United funds innovative research, offers free resources and personalized support, and advocates at state and national levels for more accessible and affordable healthcare for all patients. To learn more, visit www.BloodCancerUnited.org.
Media contact:
Kathy Melley, Blood Cancer United